These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
296 related articles for article (PubMed ID: 26840363)
1. Design, synthesis and biological evaluation of 3'-benzylated analogs of 3'-epi-neoponkoranol as potent α-glucosidase inhibitors. Liu D; He W; Wang Z; Liu L; Wang C; Zhang C; Wang C; Wang Y; Tanabe G; Muraoka O; Wu X; Wu L; Xie W Eur J Med Chem; 2016 Mar; 110():224-36. PubMed ID: 26840363 [TBL] [Abstract][Full Text] [Related]
2. Isolation, structure identification and SAR studies on thiosugar sulfonium salts, neosalaprinol and neoponkoranol, as potent α-glucosidase inhibitors. Xie W; Tanabe G; Akaki J; Morikawa T; Ninomiya K; Minematsu T; Yoshikawa M; Wu X; Muraoka O Bioorg Med Chem; 2011 Mar; 19(6):2015-22. PubMed ID: 21345683 [TBL] [Abstract][Full Text] [Related]
3. Highly Diastereoselective Route to α-Glucosidase Inhibitors, Neosalacinol and Neoponkoranol. Tanabe G; Matsuda Y; Oka M; Kunikata Y; Tsutsui N; Xie W; Balakishan G; Amer MF; Marumoto S; Muraoka O J Org Chem; 2016 Apr; 81(8):3407-15. PubMed ID: 27015084 [TBL] [Abstract][Full Text] [Related]
5. Synthesis, α-glucosidase inhibitory, cytotoxicity and docking studies of 2-aryl-7-methylbenzimidazoles. Taha M; Ismail NH; Imran S; Mohamad MH; Wadood A; Rahim F; Saad SM; Rehman AU; Khan KM Bioorg Chem; 2016 Apr; 65():100-9. PubMed ID: 26894559 [TBL] [Abstract][Full Text] [Related]
6. Elongation of the side chain by linear alkyl groups increases the potency of salacinol, a potent α-glucosidase inhibitor from the Ayurvedic traditional medicine "Salacia," against human intestinal maltase. Takashima K; Sakano M; Kinouchi E; Nakamura S; Marumoto S; Ishikawa F; Ninomiya K; Nakanishi I; Morikawa T; Tanabe G Bioorg Med Chem Lett; 2021 Feb; 33():127751. PubMed ID: 33347966 [TBL] [Abstract][Full Text] [Related]
7. Inhibitory activity evaluation and mechanistic studies of tetracyclic oxindole derivatives as α-glucosidase inhibitors. Sun H; Zhang Y; Ding W; Zhao X; Song X; Wang D; Li Y; Han K; Yang Y; Ma Y; Wang R; Wang D; Yu P Eur J Med Chem; 2016 Nov; 123():365-378. PubMed ID: 27487567 [TBL] [Abstract][Full Text] [Related]
8. Synthesis and biological evaluation of novel 1,2,4-triazine derivatives bearing carbazole moiety as potent α-glucosidase inhibitors. Wang G; Wang J; He D; Li X; Li J; Peng Z Bioorg Med Chem Lett; 2016 Jun; 26(12):2806-2809. PubMed ID: 27177827 [TBL] [Abstract][Full Text] [Related]
9. Design, synthesis and biological evaluation of novel coumarin thiazole derivatives as α-glucosidase inhibitors. Wang G; He D; Li X; Li J; Peng Z Bioorg Chem; 2016 Apr; 65():167-74. PubMed ID: 26964016 [TBL] [Abstract][Full Text] [Related]
10. Novel tetrahydrobenzo[b]thiophen-2-yl)urea derivatives as novel α-glucosidase inhibitors: Synthesis, kinetics study, molecular docking, and in vivo anti-hyperglycemic evaluation. Xie HX; Zhang J; Li Y; Zhang JH; Liu SK; Zhang J; Zheng H; Hao GZ; Zhu KK; Jiang CS Bioorg Chem; 2021 Oct; 115():105236. PubMed ID: 34411978 [TBL] [Abstract][Full Text] [Related]
11. Synthesis, in vitro evaluation and molecular docking studies of biscoumarin thiourea as a new inhibitor of α-glucosidases. Zawawi NK; Taha M; Ahmat N; Ismail NH; Wadood A; Rahim F; Rehman AU Bioorg Chem; 2015 Dec; 63():36-44. PubMed ID: 26432614 [TBL] [Abstract][Full Text] [Related]
12. 3-Benzyl(phenethyl)-2-thioxobenzo[g]quinazolines as a new class of potent α-glucosidase inhibitors: synthesis and molecular docking study. Al-Salahi R; Ahmad R; Anouar E; Iwana Nor Azman NI; Marzouk M; Abuelizz HA Future Med Chem; 2018 Aug; 10(16):1889-1905. PubMed ID: 29882426 [TBL] [Abstract][Full Text] [Related]
13. Hydrophobic substituents increase the potency of salacinol, a potent α-glucosidase inhibitor from Ayurvedic traditional medicine 'Salacia'. Tanabe G; Xie W; Balakishan G; Amer MF; Tsutsui N; Takemura H; Nakamura S; Akaki J; Ninomiya K; Morikawa T; Nakanishi I; Muraoka O Bioorg Med Chem; 2016 Aug; 24(16):3705-15. PubMed ID: 27325449 [TBL] [Abstract][Full Text] [Related]
14. Synthesis and molecular docking studies of potent α-glucosidase inhibitors based on biscoumarin skeleton. Khan KM; Rahim F; Wadood A; Kosar N; Taha M; Lalani S; Khan A; Fakhri MI; Junaid M; Rehman W; Khan M; Perveen S; Sajid M; Choudhary MI Eur J Med Chem; 2014 Jun; 81():245-52. PubMed ID: 24844449 [TBL] [Abstract][Full Text] [Related]
15. Synthesis, α-glucosidase inhibitory and molecular docking studies of prenylated and geranylated flavones, isoflavones and chalcones. Sun H; Li Y; Zhang X; Lei Y; Ding W; Zhao X; Wang H; Song X; Yao Q; Zhang Y; Ma Y; Wang R; Zhu T; Yu P Bioorg Med Chem Lett; 2015 Oct; 25(20):4567-71. PubMed ID: 26351039 [TBL] [Abstract][Full Text] [Related]
16. Synthesis, biological evaluation and molecular docking study of N-arylbenzo[d]oxazol-2-amines as potential α-glucosidase inhibitors. Wang G; Peng Z; Wang J; Li J; Li X Bioorg Med Chem; 2016 Nov; 24(21):5374-5379. PubMed ID: 27614916 [TBL] [Abstract][Full Text] [Related]
17. A new series of Schiff base derivatives bearing 1,2,3-triazole: Design, synthesis, molecular docking, and α-glucosidase inhibition. Nasli-Esfahani E; Mohammadi-Khanaposhtani M; Rezaei S; Sarrafi Y; Sharafi Z; Samadi N; Faramarzi MA; Bandarian F; Hamedifar H; Larijani B; Hajimiri M; Mahdavi M Arch Pharm (Weinheim); 2019 Aug; 352(8):e1900034. PubMed ID: 31330079 [TBL] [Abstract][Full Text] [Related]
18. Synthesis, in vitro evaluation and molecular docking studies of novel triazine-triazole derivatives as potential α-glucosidase inhibitors. Wang G; Peng Z; Wang J; Li X; Li J Eur J Med Chem; 2017 Jan; 125():423-429. PubMed ID: 27689725 [TBL] [Abstract][Full Text] [Related]
19. Synthesis, Biological Evaluation and Molecular Docking Study of 2-Substituted-4,6-Diarylpyrimidines as α-Glucosidase Inhibitors. Gong Z; Xie Z; Qiu J; Wang G Molecules; 2017 Oct; 22(11):. PubMed ID: 29084182 [TBL] [Abstract][Full Text] [Related]
20. Design, synthesis and biological evaluation of novel (E)-2-benzylidene-N-(3-cyano-4,5,6,7-tetrahydrobenzo[b]thiophen-2-yl)hydrazine-1-carboxamide derivatives as α-glucosidase inhibitors. Zhang JH; Xie HX; Li Y; Wang KM; Song Z; Zhu KK; Fang L; Zhang J; Jiang CS Bioorg Med Chem Lett; 2021 Nov; 52():128413. PubMed ID: 34634473 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]